SCHEMBL19300026

SCHEMBL19300026

C=C1CC(CC#N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23299272 0.75
SCHEMBL19253530 0.74
SCHEMBL2477631 0.69 IDO1 (0.42)
SCHEMBL19253470 0.69 DRD3 (0.34)
SCHEMBL2162286 0.67 JAK2 (0.33)
SCHEMBL365047 0.67
SCHEMBL24197645 0.67 JAK2 (0.33)
SCHEMBL13907209 0.67 JAK2 (0.33)
SCHEMBL15709734 0.67 ALDH1A1 (0.30)
Hydrochloric Acid SCHEMBL30503012 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119330909-A Protein tyrosine phosphatase inhibitors 上海齐鲁制药研究中心有限公司 2025-01-21 CN disclosed
CN-111848423-B Preparation method of tert-butyl 3-oxocyclobutylcarbamate 尚科生物医药(上海)有限公司 2022-10-14 CN disclosed
WO-2017144995-A1 PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES AS JAK-INHIBITORS PFIZER INC. (US) 2017-08-31 WO disclosed